Cargando…

CX3CR1 deficiency suppresses activation and neurotoxicity of microglia/macrophage in experimental ischemic stroke

BACKGROUND: Chemokine (C-X3-C motif) ligand 1 (CX3CL1)/ CX3C chemokine receptor 1 (CX3CR1) signaling is important in modulating the communication between neurons and resident microglia/migrated macrophages in the central nervous system (CNS). Although CX3CR1 deficiency is associated with an improved...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Zhiwei, Gan, Yan, Liu, Qiang, Yin, Jun-Xiang, Liu, Qingwei, Shi, Jiong, Shi, Fu-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942808/
https://www.ncbi.nlm.nih.gov/pubmed/24490760
http://dx.doi.org/10.1186/1742-2094-11-26
_version_ 1782479128472059904
author Tang, Zhiwei
Gan, Yan
Liu, Qiang
Yin, Jun-Xiang
Liu, Qingwei
Shi, Jiong
Shi, Fu-Dong
author_facet Tang, Zhiwei
Gan, Yan
Liu, Qiang
Yin, Jun-Xiang
Liu, Qingwei
Shi, Jiong
Shi, Fu-Dong
author_sort Tang, Zhiwei
collection PubMed
description BACKGROUND: Chemokine (C-X3-C motif) ligand 1 (CX3CL1)/ CX3C chemokine receptor 1 (CX3CR1) signaling is important in modulating the communication between neurons and resident microglia/migrated macrophages in the central nervous system (CNS). Although CX3CR1 deficiency is associated with an improved outcome following ischemic brain injury, the mechanism of this observation is largely unknown. The aim of this study was to investigate how CX3CR1 deficiency influences microglia/macrophage functions in the context of its protection following brain ischemia. METHODS: Wild-type (WT) and CX3CR1-deficient (CX3CR1(-/-)) mice were subjected to transient middle cerebral artery occlusion (MCAO) and reperfusion. The ischemic brain damage was monitored by rodent high-field magnetic resonance imaging. Neurological deficit was assessed daily. Neuronal apoptotic death and reactive oxygen species (ROS) production were analyzed by immunostaining and live imaging. Activation/inflammatory response of microglia/macrophage were assessed using immunohistochemistry, flow cytometry, 5-bromo-2-deoxyuridine labeling, cytokine ELISA, and real-time PCR. RESULTS: CX3CR1(-/-) mice displayed significantly smaller infarcts and less severe neurological deficits compared to WT controls, following MCAO. In addition, CX3CR1(-/-) MCAO mice displayed fewer apoptotic neurons and reduced ROS levels. Impaired CX3CR1 signaling abrogated the recruitment of monocyte-derived macrophages from the periphery, suppressed the proliferation of CNS microglia and infiltrated macrophage, facilitated the alternative activation (M2 state) of microglia/macrophages, and attenuated their ability to synthesize and release inflammatory cytokines. CONCLUSION: Our results suggest that inhibition of CX3CR1 signaling could function as a therapeutic modality in ischemic brain injury, by reducing recruitment of peripheral macrophages and expansion/activation of CNS microglia and macrophages, resulting in protection of neurological function.
format Online
Article
Text
id pubmed-3942808
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39428082014-03-06 CX3CR1 deficiency suppresses activation and neurotoxicity of microglia/macrophage in experimental ischemic stroke Tang, Zhiwei Gan, Yan Liu, Qiang Yin, Jun-Xiang Liu, Qingwei Shi, Jiong Shi, Fu-Dong J Neuroinflammation Research BACKGROUND: Chemokine (C-X3-C motif) ligand 1 (CX3CL1)/ CX3C chemokine receptor 1 (CX3CR1) signaling is important in modulating the communication between neurons and resident microglia/migrated macrophages in the central nervous system (CNS). Although CX3CR1 deficiency is associated with an improved outcome following ischemic brain injury, the mechanism of this observation is largely unknown. The aim of this study was to investigate how CX3CR1 deficiency influences microglia/macrophage functions in the context of its protection following brain ischemia. METHODS: Wild-type (WT) and CX3CR1-deficient (CX3CR1(-/-)) mice were subjected to transient middle cerebral artery occlusion (MCAO) and reperfusion. The ischemic brain damage was monitored by rodent high-field magnetic resonance imaging. Neurological deficit was assessed daily. Neuronal apoptotic death and reactive oxygen species (ROS) production were analyzed by immunostaining and live imaging. Activation/inflammatory response of microglia/macrophage were assessed using immunohistochemistry, flow cytometry, 5-bromo-2-deoxyuridine labeling, cytokine ELISA, and real-time PCR. RESULTS: CX3CR1(-/-) mice displayed significantly smaller infarcts and less severe neurological deficits compared to WT controls, following MCAO. In addition, CX3CR1(-/-) MCAO mice displayed fewer apoptotic neurons and reduced ROS levels. Impaired CX3CR1 signaling abrogated the recruitment of monocyte-derived macrophages from the periphery, suppressed the proliferation of CNS microglia and infiltrated macrophage, facilitated the alternative activation (M2 state) of microglia/macrophages, and attenuated their ability to synthesize and release inflammatory cytokines. CONCLUSION: Our results suggest that inhibition of CX3CR1 signaling could function as a therapeutic modality in ischemic brain injury, by reducing recruitment of peripheral macrophages and expansion/activation of CNS microglia and macrophages, resulting in protection of neurological function. BioMed Central 2014-02-03 /pmc/articles/PMC3942808/ /pubmed/24490760 http://dx.doi.org/10.1186/1742-2094-11-26 Text en Copyright © 2014 Tang et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Tang, Zhiwei
Gan, Yan
Liu, Qiang
Yin, Jun-Xiang
Liu, Qingwei
Shi, Jiong
Shi, Fu-Dong
CX3CR1 deficiency suppresses activation and neurotoxicity of microglia/macrophage in experimental ischemic stroke
title CX3CR1 deficiency suppresses activation and neurotoxicity of microglia/macrophage in experimental ischemic stroke
title_full CX3CR1 deficiency suppresses activation and neurotoxicity of microglia/macrophage in experimental ischemic stroke
title_fullStr CX3CR1 deficiency suppresses activation and neurotoxicity of microglia/macrophage in experimental ischemic stroke
title_full_unstemmed CX3CR1 deficiency suppresses activation and neurotoxicity of microglia/macrophage in experimental ischemic stroke
title_short CX3CR1 deficiency suppresses activation and neurotoxicity of microglia/macrophage in experimental ischemic stroke
title_sort cx3cr1 deficiency suppresses activation and neurotoxicity of microglia/macrophage in experimental ischemic stroke
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942808/
https://www.ncbi.nlm.nih.gov/pubmed/24490760
http://dx.doi.org/10.1186/1742-2094-11-26
work_keys_str_mv AT tangzhiwei cx3cr1deficiencysuppressesactivationandneurotoxicityofmicrogliamacrophageinexperimentalischemicstroke
AT ganyan cx3cr1deficiencysuppressesactivationandneurotoxicityofmicrogliamacrophageinexperimentalischemicstroke
AT liuqiang cx3cr1deficiencysuppressesactivationandneurotoxicityofmicrogliamacrophageinexperimentalischemicstroke
AT yinjunxiang cx3cr1deficiencysuppressesactivationandneurotoxicityofmicrogliamacrophageinexperimentalischemicstroke
AT liuqingwei cx3cr1deficiencysuppressesactivationandneurotoxicityofmicrogliamacrophageinexperimentalischemicstroke
AT shijiong cx3cr1deficiencysuppressesactivationandneurotoxicityofmicrogliamacrophageinexperimentalischemicstroke
AT shifudong cx3cr1deficiencysuppressesactivationandneurotoxicityofmicrogliamacrophageinexperimentalischemicstroke